Universal Diagnostics is a Spain-based biotechnology company that develops minimally invasive blood-focused in-vitro diagnostics systems for the treatment of cancer.
-
Aug 14, 2024
-
PreciseDx is a New York-based AI platform that provides solutions such as cancer risk stratification and personalized treatment analytics for the healthcare industry.
$20.7M
Feb 19, 2024
-
Freenome is a California-based biotechnology company that researches and
develops blood tests for the early detection of cancer.
$254M
Feb 14, 2024
-
Universal Diagnostics is a Spain-based biotechnology company that develops minimally invasive blood-focused in-vitro diagnostics systems for the treatment of cancer.
$70M
Nov 19, 2023
-
Sharecare is a Georgia-based healthcare technology company that offers services such as digital therapeutics and mental wellness support for individuals and businesses.
-
Jul 11, 2019
-
Frequently Asked Questions about Quest Diagnostics
What is Quest Diagnostics investing in?
Quest Diagnostics has invested in 5 companies including Universal Diagnostics, PreciseDx and Freenome
What company did Quest Diagnostics invest in?
Quest Diagnostics invested in a total 5 companies including Universal Diagnostics, PreciseDx and Freenome
What are the top 5 investments by Quest Diagnostics?
The top companies in which Quest Diagnostics invested are Universal Diagnostics, PreciseDx, Freenome, Universal Diagnostics and Sharecare
